 double-blind placebo-controlled trial somatostatin variceal bleeding Emergency control prevention early variceal rebleeding randomized double-blind placebo-controlled trial somatostatin patients esophageal varices placebo somatostatin initial bolus somatostatin continuous infusion micrograms/h identical administration placebo control bleeding prevention early rebleeding varices Failure somatostatin patients placebo patients time placebo blood plasma hour drug infusion trial drug somatostatin group median unit/h Use balloon tamponade somatostatin-treated patients average effect somatostatin reduction hazard failure confidence interval adjustment severity liver disease variable significant influence time failure difference mortality admission placebo somatostatin complications somatostatin safe effective placebo control variceal bleeding